FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Human Drugs

Germitecs Chronos Gets De Novo Marketing Pass

FDA awards de novo marketing clearance to Germitecs Chronos automated disinfection device for reducing the risk of cross-contamination with ultrasound...

latest-news-card-1
Federal Register

Guide on X-Ray Device Regulations

Federal Register notice: FDA makes available a final guidance entitled Clarification of Radiation Control Regulations for Manufacturers of Diagnostic ...

latest-news-card-1
FDA General

FDA Discusses Optimizing Advisory Committees

FDA commissioner Robert Califf and other top officials outline areas the agency believes can be optimized to help improve the advice received from adv...

latest-news-card-1
Medical Devices

FDA Approves Motiva Breast Implants

FDA approves Establishment Labs Holdings Motiva SmoothSilk Ergonomix and Motiva SmoothSilk Round breast implants for breast augmentation.

latest-news-card-1
Human Drugs

Dupixent Approved for COPD Add On

FDA approves Sanofi and Regenerons Dupixent (dupilumab) as an add-on maintenance treatment for adults with inadequately controlled chronic obstructive...

latest-news-card-1
Human Drugs

FDA OKs New Schizophrenia Drug

FDA approves Bristol-Myers Squibbs Cobenfy (xanomeline and trospium chloride) capsules for treating schizophrenia in adults.

latest-news-card-1
Federal Register

Advisory Committee Consumer Reps Sought

Federal Register notice: FDA seeks consumer organizations interested in participating in the selection process for voting or nonvoting consumer repres...

latest-news-card-1
Federal Register

OMB Clears 4 Informaton Collections

Federal Register notice: FDA announces that four information collections have been approved by OMB.

latest-news-card-1
Biologics

Appeals Court Gives FDA a Win on Stem Cells

The U.S. 9th Circuit Court of Appeals reverses an earlier California lower court decision that ruled a stem cell treatment firm is exempt from FDA reg...

latest-news-card-1
Human Drugs

FDA-passed Parkinsons Drug Part of Falsified Research Probe

An investigation by the journal Science questions the data behind a Parkinsons drug under development by Prothena and based on falsified research invo...